Skip to content

Buy Marksans Pharma; target of Rs 80: Arihant Capital

Arihant Capital is bullish on Marksans Pharma has recommended buy rating on the stock with a target price of Rs 80 in its research report dated August 19, 2022.

Read More

Leave a Reply

Your email address will not be published. Required fields are marked *

en_USEnglish